Nancy E. Dempze’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.2M | Buy |
7,180
+117
| +2% | +$52.1K | 1.84% | 23 |
|
|
2025
Q1 | $3.42M | Buy |
7,063
+986
| +16% | +$478K | 2.06% | 21 |
|
|
2024
Q4 | $2.45M | Buy |
6,077
+1,208
| +25% | +$486K | 1.41% | 27 |
|
|
2024
Q3 | $2.26M | Buy |
4,869
+2,286
| +89% | +$1.06M | 1.26% | 29 |
|
|
2024
Q2 | $1.21M | Buy |
2,583
+1,878
| +266% | +$880K | 0.83% | 35 |
|
|
2024
Q1 | $295K | Buy |
+705
| New | +$295K | 0.22% | 52 |
|